Role of liver X receptors alpha agonist on expressions of LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB in Kupffer cells
|Updated:2026-03-12
|
Role of liver X receptors alpha agonist on expressions of LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB in Kupffer cells
Role of liver X receptors alpha agonist on expressions of LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB in Kupffer cells
解放军医学杂志(英文版)2008年第2期 页码:70-75
Affiliations:
Author bio:
Funds:
the National Natural Science Foundation of China (30530360 and 30772098)
DOI:
中图分类号:R363
纸质出版:2008
Accepted:
Scan QR Code
Role of liver X receptors alpha agonist on expressions of LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB in Kupffer cells[J]. 解放军医学杂志(英文版), 2008,(2):70-75.
[1].Role of liver X receptors alpha agonist on expressions of LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB in Kupffer cells[J].Journal of Medical Colleges of PLA,2008(02):70-75.
Role of liver X receptors alpha agonist on expressions of LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB in Kupffer cells[J]. 解放军医学杂志(英文版), 2008,(2):70-75.DOI:
[1].Role of liver X receptors alpha agonist on expressions of LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB in Kupffer cells[J].Journal of Medical Colleges of PLA,2008(02):70-75.DOI:
Role of liver X receptors alpha agonist on expressions of LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB in Kupffer cells
摘要
Abstract
<正>Objective:To explore the role of activated liver X receptor a (LXRα) on the expressions of interleukin-1 receptor associated kinase-4 (IRAK-4) and NF-kappaB (NF-κB) in the inflammatory response which induced by LPS in the Kupffer cells and to investigate the possible mechanisms of LXRαnegative regulation of inflammatory response. Methods:The Kupffer cells were isolated from male Kunming mice by collagen perfusion in situ.And these cells were divided into 4 groups:normal control group
LPS treatment group
LXRαagonist T0901317 treatment group
LPS and T0901317 combined treatment group.The LPS treatment group were treated with a final concentration of 1μg/ml LPS in RPMI 1640 and cultured for 6 h
the T0901317 treatment group were treated with a final concentration of 5μg/ml in RPMI 1640 and cultured for 24 h
and the combined treatment group received pre-culture for 24 h with a final concentration of 1μg/ml T0901317 in RPMI 1640 and then cultured for 6 h with a final concentration of 5μg/ml LPS in RPM! 1640.All groups were cultured for 30 h.The expression of LXRα
IRAK-4 and NF-κB at mRNA and protein levels were detected by real-time PCR and Western blotting
and the TNF-αand IL-1βlevels were detected by ELISA. Results:The levels of LXRαmRNA and protein were highest in T0901317 group
and lowest in LPS group (P<0.05). The level of IRAK4 and NF-κB mRNAs and proteins were evidently lower in the Combined-treated group than in LPS group (P<0.05).And the level of TNF-αand IL-1 were observed highest in LPS group (P<0.05)
but no difference among the Control group
T0901317 group and Combined-treated group (P>0.05).Conclusion:These date suggest that the LXR agonists can effectively up-regulate the expressions of LXRαmRNA and protein and inhibit the inflammatory response.This may be via down-regulating the expressions of IRAK4 and NF-κB at mRNA and protein levels.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.